Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Return on Invested Capital (2021 - 2025)

Pulmonx (LUNG) has disclosed Return on Invested Capital for 5 consecutive years, with 0.52% as the latest value for Q2 2025.

  • On a quarterly basis, Return on Invested Capital fell 10.0% to 0.52% in Q2 2025 year-over-year; TTM through Jun 2025 was 0.52%, a 10.0% decrease, with the full-year FY2024 number at 0.42%, down 4.0% from a year prior.
  • Return on Invested Capital was 0.52% for Q2 2025 at Pulmonx, down from 0.49% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.16% in Q1 2021 to a low of 0.52% in Q2 2025.
  • A 5-year average of 0.33% and a median of 0.34% in 2022 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: decreased -12bps in 2022, then dropped -6bps in 2024.
  • Pulmonx's Return on Invested Capital stood at 0.22% in 2021, then tumbled by -53bps to 0.34% in 2022, then decreased by -5bps to 0.35% in 2023, then plummeted by -31bps to 0.46% in 2024, then dropped by -13bps to 0.52% in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Return on Invested Capital are 0.52% (Q2 2025), 0.49% (Q1 2025), and 0.46% (Q4 2024).